Analytical laboratory instrument and software provider, Waters Corporation (MA, USA) have officially announced plans to acquire Swiss-based laboratory automation technology innovator Andrew Alliance (Geneva, Switzerland).
Browsing: Collaborations and mergers
BioAgilytix (NC, USA), a provider of large-molecule bioanalytical testing services, has announced the acquisition of the Boston-based CRO, Cambridge Biomedical (MA, USA), which also specializes in large-molecule bioanalysis.
Drug discovery and development company, Evotec (Hamburg, Germany), enter a new collaboration agreement with Asia’s largest pharmaceutical company, Takeda (Tokyo, Japan), which promises to discover clinical candidates across multiple therapeutic areas.
Shimadzu (Kyoto, Japan), an international provider of analytical instrumentation, has opened a branch office in Stockholm (Sweden).
Thermo Fisher Scientific (MA, USA) and Cedars-Sinai (CA, USA) announce a collaboration that promises to develop robust, sensitive and reliable LC—MS based workflows for clinical research applications.
Verify Life Science LLC (CA, USA), health and life sciences company under Alphabet, recently announced its partnerships with four major pharmaceutical companies to allow them to move into the clinical trial market.
Global leaders in life sciences and nonclinical drug development, Envigo (Huntingdon, UK) and LabCorp (NC, USA), have signed an innovative agreement in a bid to expand nonclinical drug development capabilities and create an independent research models provider.
Charles River Laboratories have signed an agreement to acquire Citoxlab for $510 million in a deal that aims to expand their global scale and scientific service portfolio.
Bristol-Myers Squibb (NY, USA) have announced that they will be acquiring Celgene (NJ, USA) this year for a cost of $74 billion.
This week’s round-up includes the discovery of a novel method for mass spectometry and thermal desorption, as well as an update from Waters Corp (MA, USA) on their aquisition of DESI technology exclusive rights.